Cargando…

Prodromal frontotemporal dementia: clinical features and predictors of progression

BACKGROUND: The prodromal phase of frontotemporal dementia (FTD) is still not well characterized, and conversion rates to dementia and predictors of progression at 1-year follow-up are currently unknown. METHODS: In this retrospective study, disease severity was assessed using the global CDR plus NA...

Descripción completa

Detalles Bibliográficos
Autores principales:	Benussi, Alberto, Ashton, Nicholas J., Karikari, Thomas K., Alberici, Antonella, Saraceno, Claudia, Ghidoni, Roberta, Benussi, Luisa, Zetterberg, Henrik, Blennow, Kaj, Borroni, Barbara
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2021
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8594126/ https://www.ncbi.nlm.nih.gov/pubmed/34782010 http://dx.doi.org/10.1186/s13195-021-00932-2

Ejemplares similares

Sex influences clinical phenotype in frontotemporal dementia
por: Pengo, Marta, et al.
Publicado: (2022)

Toward a Glutamate Hypothesis of Frontotemporal Dementia
por: Benussi, Alberto, et al.
Publicado: (2019)

Exploring Neurofilament Light Chain and Exosomes in the Genetic Forms of Frontotemporal Dementia
por: Zanardini, Roberta, et al.
Publicado: (2022)

Differences and similarities between familial and sporadic frontotemporal dementia: An Italian single‐center cohort study
por: Benussi, Alberto, et al.
Publicado: (2022)

Classification accuracy of blood-based and neurophysiological markers in the differential diagnosis of Alzheimer’s disease and frontotemporal lobar degeneration
por: Benussi, Alberto, et al.
Publicado: (2022)

Transcranial stimulation in frontotemporal dementia: A randomized, double‐blind, sham‐controlled trial
por: Benussi, Alberto, et al.
Publicado: (2020)

Biological, Neuroimaging, and Neurophysiological Markers in Frontotemporal Dementia: Three Faces of the Same Coin
por: Borroni, Barbara, et al.
Publicado: (2018)

Plasma Extracellular Vesicle Size and Concentration Are Altered in Alzheimer’s Disease, Dementia With Lewy Bodies, and Frontotemporal Dementia
por: Longobardi, Antonio, et al.
Publicado: (2021)

Phenotypic Heterogeneity of Monogenic Frontotemporal Dementia
por: Benussi, Alberto, et al.
Publicado: (2015)

Brain-derived tau: a novel blood-based biomarker for Alzheimer’s disease-type neurodegeneration
por: Gonzalez-Ortiz, Fernando, et al.
Publicado: (2022)

Genome Wide Association Study and Next Generation Sequencing: A Glimmer of Light Toward New Possible Horizons in Frontotemporal Dementia Research
por: Ciani, Miriam, et al.
Publicado: (2019)

Modifiable potential risk factors in familial and sporadic frontotemporal dementia
por: Soppela, Helmi, et al.
Publicado: (2022)

Is it time for biomarker-based diagnostic criteria for prodromal Alzheimer's disease?
por: Blennow, Kaj, et al.
Publicado: (2010)

Molecular Pathways Bridging Frontotemporal Lobar Degeneration and Psychiatric Disorders
por: Zanardini, Roberta, et al.
Publicado: (2016)

Analytical and clinical validation of a blood progranulin ELISA in frontotemporal dementias
por: Meda, Francisco, et al.
Publicado: (2023)

Recent advances in understanding frontotemporal degeneration
por: Borroni, Barbara, et al.
Publicado: (2019)

The Missing Heritability of Sporadic Frontotemporal Dementia: New Insights from Rare Variants in Neurodegenerative Candidate Genes
por: Ciani, Miriam, et al.
Publicado: (2019)

Anti-AMPA GluA3 antibodies in Frontotemporal dementia: a new molecular target
por: Borroni, B., et al.
Publicado: (2017)

Loss of Neuroprotective Factors in Neurodegenerative Dementias: The End or the Starting Point?
por: Benussi, Luisa, et al.
Publicado: (2017)

Editorial: Blood Biomarkers of Neurodegenerative Diseases
por: Karikari, Thomas K., et al.
Publicado: (2022)

Proposed research criteria for prodromal behavioural variant frontotemporal dementia
por: Barker, Megan S, et al.
Publicado: (2022)

Publisher Correction: Anti-AMPA GluA3 antibodies in Frontotemporal dementia: a new molecular target
por: Borroni, B., et al.
Publicado: (2018)

Dyslexia susceptibility genes influence brain atrophy in frontotemporal dementia
por: Paternicó, Donata, et al.
Publicado: (2015)

Pathological 25 kDa C-Terminal Fragments of TDP-43 Are Present in Lymphoblastoid Cell Lines and Extracellular Vesicles from Patients Affected by Frontotemporal Lobar Degeneration and Neuronal Ceroidolipofuscinosis Carrying a GRN Mutation
por: Cimini, Sara, et al.
Publicado: (2022)

Plasma Small Extracellular Vesicle Cathepsin D Dysregulation in GRN/C9orf72 and Sporadic Frontotemporal Lobar Degeneration
por: Bellini, Sonia, et al.
Publicado: (2022)

Progression of Behavioral Disturbances and Neuropsychiatric Symptoms in Patients With Genetic Frontotemporal Dementia
por: Benussi, Alberto, et al.
Publicado: (2021)

Experimental Disease-Modifying Agents for Frontotemporal Lobar Degeneration
por: Giunta, Marcello, et al.
Publicado: (2021)

Cognitive Reserve in Granulin-Related Frontotemporal Dementia: from Preclinical to Clinical Stages
por: Premi, Enrico, et al.
Publicado: (2013)

Longitudinal changes in qualitative aspects of semantic fluency in presymptomatic and prodromal genetic frontotemporal dementia
por: Jiskoot, Lize C., et al.
Publicado: (2023)

Clinical Value of Longitudinal Serum Neurofilament Light Chain in Prodromal Genetic Frontotemporal Dementia
por: Giannini, Lucia A.A., et al.
Publicado: (2023)

Novel CSF biomarkers in genetic frontotemporal dementia identified by proteomics
por: van der Ende, Emma L., et al.
Publicado: (2019)

Plasma neurofilament light protein correlates with diffusion tensor imaging metrics in frontotemporal dementia
por: Spotorno, Nicola, et al.
Publicado: (2020)

Cerebrospinal Fluid EV Concentration and Size Are Altered in Alzheimer’s Disease and Dementia with Lewy Bodies
por: Longobardi, Antonio, et al.
Publicado: (2022)

Synaptic proteins in CSF as potential novel biomarkers for prognosis in prodromal Alzheimer’s disease
por: Duits, Flora H., et al.
Publicado: (2018)

Synergistic Association between Plasma Aβ(1–42) and p-tau in Alzheimer’s Disease but Not in Parkinson’s Disease or Frontotemporal Dementia
por: Chiu, Ming-Jang, et al.
Publicado: (2021)

The PINK1 p.Asn521Thr Variant Is Associated with Earlier Disease Onset in GRN/C9orf72 Frontotemporal Lobar Degeneration
por: Rossi, Giacomina, et al.
Publicado: (2022)

Accurate risk estimation of β-amyloid positivity to identify prodromal Alzheimer's disease: Cross-validation study of practical algorithms
por: Palmqvist, Sebastian, et al.
Publicado: (2019)

Progranulin Mutations Affects Brain Oscillatory Activity in Fronto-Temporal Dementia
por: Moretti, Davide V., et al.
Publicado: (2016)

CSF synaptic protein concentrations are raised in those with atypical Alzheimer’s disease but not frontotemporal dementia
por: Clarke, Mica T. M., et al.
Publicado: (2019)

Regulatory miRNAs in Cardiovascular and Alzheimer’s Disease: A Focus on Copper
por: Sacco, Anna, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_07n8artechoe28v5aoaem3hm6m